Buy Qvar

Qvar

What is Qvar?

Qvar is a prescription inhaled corticosteroid medication used in the management of asthma. It contains beclomethasone dipropionate as its active ingredient and is supplied in 200 µg capsules that are placed in a breath-activated inhaler device. In the United Kingdom, Qvar is classified as a Prescription-Only Medicine (POM) and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The product is marketed by GlaxoSmithKline (GSK).

How Qvar Works in the Body

Beclomethasone dipropionate belongs to the class of inhaled corticosteroids (ICS). After inhalation, the drug is deposited onto the airway lining where it:

• Activates glucocorticoid receptors in airway epithelial cells.
• Suppresses the production of inflammatory cytokines (e.g., interleukin-4, interleukin-5) and reduces recruitment of eosinophils and mast cells.
• Decreases airway hyper-responsiveness, leading to less swelling and mucus production.

Because the medication is delivered directly to the lungs, systemic exposure is low, which limits the risk of typical oral corticosteroid side effects. The therapeutic effect usually begins within a few hours, with maximal anti-inflammatory benefit reached after several days of consistent use.

Conditions Treated by Qvar

Qvar is approved in the UK for the regular maintenance treatment of asthma in patients aged 5 years and older. It is intended to:

• Reduce the frequency and severity of asthma symptoms.
• Decrease the need for rescue (short-acting bronchodilator) medication.
• Prevent asthma exacerbations that could require oral steroids or hospital admission.

Qvar is not a rescue medication and should not be used to relieve an acute asthma attack.

Evidence-Based Off-Label Uses

• Chronic obstructive pulmonary disease (COPD) - Some clinical guidelines mention that inhaled corticosteroids may be added to COPD therapy in patients with frequent exacerbations, but Qvar is not licensed for COPD in the UK. Use for COPD must be decided by a specialist and is considered off-label.
• Allergic rhinitis - There is limited evidence that low-dose inhaled corticosteroids can help persistent nasal symptoms, but Qvar is not approved for this indication.

Disclaimer: Off-label use requires medical supervision, a clear assessment of risks and benefits, and documentation of informed consent.

Who Should (Not) Use Qvar?

Ideal Candidates

• Adults and children (≥ 5 years) with persistent asthma who need daily anti-inflammatory therapy.
• Patients who can demonstrate correct inhaler technique and adhere to a regular dosing schedule.

Absolute Contra-indications

• Known hypersensitivity to beclomethasone dipropionate, any other inhaled corticosteroid, or the inhaler device components.
• Acute episodes of severe asthma (status asthmaticus) that require immediate emergency treatment.

Relative Contra-indications

• Pregnancy: Limited human data; inhaled corticosteroids are generally considered low-risk, but the medication should be used only if the potential benefit outweighs the risk (Pregnancy Category B in the UK).
• Breastfeeding: Small amounts may be excreted in breast milk; discuss with a healthcare professional.
• Active, untreated oral fungal infection (thrush).
• Severe liver impairment: May increase systemic exposure; dose adjustment may be needed.

Special Populations

• Pediatric patients: Growth monitoring is recommended during long-term therapy.
• Elderly: No specific dose reduction is required, but comorbidities and polypharmacy should be reviewed.
• Renal or hepatic dysfunction: No routine dose change, but clinicians should monitor for systemic corticosteroid effects.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Hoarseness or voice change.
• Oral thrush (candidiasis) - often preventable by rinsing the mouth with water after each use.
• Mild cough or throat irritation.
• Transient headache.

Serious Adverse Events

• Adrenal suppression - Rare but possible with high-dose or prolonged use; signs include fatigue, nausea, low blood pressure.
• Osteoporosis - Long-term systemic corticosteroid exposure can affect bone density.
• Glaucoma or cataract formation - Very uncommon with inhaled therapy, but periodic eye examinations are advisable for high-dose users.
• Allergic reactions - Rash, angioedema, or anaphylaxis (seek emergency care).

Drug Interactions

• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) can raise systemic beclomethasone levels; monitor for corticosteroid side effects.
• Concurrent oral or intravenous corticosteroids increase the risk of systemic effects such as adrenal suppression and hyperglycaemia.
• Antifungal agents (especially systemic azoles) may increase exposure; dose adjustment or close monitoring may be needed.

Food and Lifestyle Interactions

• No specific food restrictions, but the capsule should be kept dry; avoid exposing the inhaler to moisture.
• Alcohol does not interfere with Qvar, but excessive drinking may mask symptoms of a severe asthma flare.
• Driving: Qvar does not impair cognition; however, uncontrolled asthma symptoms could affect safe driving.
• Exercise: Use Qvar regularly as prescribed; a short-acting bronchodilator may be taken before exercise if needed.

General Advice: Always disclose all medications, supplements, and herbal products to your prescriber before starting Qvar.

How to Take Qvar

Standard Dosing (Adults)

• Initial dose: 200 µg (one capsule) inhaled twice daily (morning and evening).
• Maintenance dose: May be increased to 400 µg twice daily if asthma control is insufficient, up to a maximum of 800 µg twice daily (four capsules per day).

Pediatric Dosing (5-12 years)

• Typically 200 µg once daily, with the option to increase to 200 µg twice daily based on symptom control.

Administration Technique (Capsule Inhaler)

1. Remove a 200 µg capsule from the foil pack.
2. Insert the capsule into the designated slot of the breath-activated inhaler.
3. Exhale fully away from the device.
4. Inhale deeply and steadily through the mouthpiece, triggering the capsule to release the powdered medication.
5. Hold your breath for 10 seconds (or as long as comfortable) then exhale slowly.
6. Close the inhaler and store it upright.

Missed Dose

• If you remember a missed dose more than 4 hours before the next scheduled dose, take it immediately.
• If it is within 4 hours of the next dose, skip the missed one and continue with the regular schedule. Do not double a dose.

Overdose

• Symptoms may include severe hoarseness, oral thrush, tremor, or signs of systemic corticosteroid excess (e.g., rapid weight gain, high blood sugar).
• Seek medical attention promptly; treatment may involve temporary discontinuation and monitoring.

Discontinuation and Tapering

• For patients on high daily doses (≥ 800 µg) for more than a few weeks, gradual tapering is recommended to avoid adrenal insufficiency.
• Tapering schedules should be individualized by a prescriber, typically reducing the dose by 200 µg every 1-2 weeks while monitoring symptoms.

Monitoring and Follow-Up

• Lung function tests (spirometry or peak expiratory flow) every 3-6 months, or sooner if symptoms change.
• Inhaler technique review at each visit to ensure optimal drug delivery.
• Oral examination for signs of thrush; recommend mouth rinsing after each use.
• Growth monitoring in children (height and weight).
• Bone density assessment for patients on high doses for > 6 months, especially if additional risk factors exist.
• Blood glucose checks in diabetic patients if systemic exposure is suspected.

Storage and Handling

• Keep the inhaler below 30 °C; do not expose it to direct sunlight or high humidity.
• Store capsules in their original foil packaging until use.
• Keep the device out of reach of children; use child- resistant caps if available.
• Do not use the inhaler if the capsule appears damaged, wet, or discolored.
• Dispose of used capsules and the inhaler according to local pharmacy or waste-management guidelines.

Medication-Specific Glossary

Inhaled Corticosteroid (ICS)

A class of medication delivered directly to the lungs to reduce airway inflammation with minimal systemic absorption.

Adrenal Suppression

Decreased production of endogenous cortisol caused by prolonged exposure to corticosteroids, potentially leading to fatigue, low blood pressure, and difficulty handling stress.

Oral Thrush

A fungal infection of the mouth caused by Candida species, commonly associated with inhaled steroid use; prevented by rinsing the mouth after inhalation.

Peak Expiratory Flow (PEF)

The highest speed at which a person can exhale; used to monitor asthma control and detect early deterioration.

Systemic Bioavailability

The proportion of a drug that reaches the systemic circulation unchanged; for inhaled corticosteroids it is low, limiting whole-body side effects.

Medical Disclaimer

This article provides educational information about Qvar (beclomethasone dipropionate) and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.